Inhibrx Biosciences, Inc. (NASDAQ:INBX) Given Consensus Recommendation of “Hold” by Brokerages
Shares of Inhibrx Biosciences, Inc. (NASDAQ:INBX – Get Free Report) have been assigned an average recommendation of “Hold” from the six analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, one has issued a buy recommendation and one […]
25 Jun 08:15 · The Markets Daily